Ortho-R
-
Biologics
Ortho Regenerative Technologies Enters Into A Material Transfer Agreement With A Global Strategic Medical Company For Its Ortho-R Rotator Cuff Tear Repair Phase I/II U.S. Clinical Trial
MONTREAL, Feb. 7, 2022 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (OTC: ORTIF) (“Ortho” or the “Company“), a clinical-stage orthobiologics company focused on…
Read More » -
Biologics
Ortho Regenerative Technologies Announces Extension of FDA Clinical Hold of ORTHO-R Investigational New Drug Application
Most complex, and majority of additional information on characterization at point of care and CMC related data submitted accepted by…
Read More » -
Biologics
Ortho Regenerative Technologies Releases New Positive Histology Results From Pivotal Preclinical GLP Rotator Cuff Tear Repair Efficacy Study in Large-Animal Model
MONTREAL, July 23, 2020 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTI” or the “Company“), an emerging orthobiologics company, today announced new positive results following completion of its pivotal preclinical study report…
Read More » -
Biologics
Ortho Regenerative Technologies Announces Positive Results from Pivotal Preclinical Study in Rotator Cuff Tear Repair
Safety profile of ORTHO-R confirmed.Statistical significance over standard of care demonstrated.ORTHO-R program advancing towards clinical phase. MONTREAL, March 12, 2020 /CNW/ – Ortho…
Read More » -
Sports Medicine
Ortho RTi Announces Initiation of Pivotal Study on Ortho-R for Rotator Cuff Repair
KIRKLAND, QC, Feb. 11, 2019 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTi” or the “Company”), an emerging Orthopaedic and Sports…
Read More » -
Recon
Ortho RTi’s Data selected for Podium Presentation at International Conference
KIRKLAND, QC, Dec. 12, 2018 /PRNewswire/ – Ortho Regenerative Technologies Inc. (CSE: ORTH) (“Ortho RTi” or the “Corporation”), an emerging Orthopaedic and Sports…
Read More » -
Sports Medicine
Ortho RTi Receives Notice of Allowance for European Patent Protecting Ortho-R Technology
KIRKLAND, QC, March 8, 2018 /CNW Telbec/ – Ortho Regenerative Technologies Inc. (CSE: ORTH.CN) (“Ortho RTi” or the “Corporation”), an emerging Orthopaedic and…
Read More »